Determining the Clinical Value and Critical Pathway of GTPBP4 in Lung Adenocarcinoma Using a Bioinformatics Strategy: A Study Based on Datasets from The Cancer Genome Atlas

<div>The prognostic significance of the 12 selected target genes for LUAD. Low expression of DDX5 and high expression of EIF6, DDX18, MRTO4, NOP2, PES1, RPF2, RPL4, WDR36, BOP1, DDX47, and DDX56 were associated with poor prognosis of LUAD patients.</div>

BioMed Research International

fig6

Figure 6

Figure 6: Determining the Clinical Value and Critical Pathway of GTPBP4 in Lung Adenocarcinoma Using a Bioinformatics Strategy: A Study Based on Datasets from The Cancer Genome Atlas 

Figure 6 | Determining the Clinical Value and Critical Pathway of GTPBP4 in Lung Adenocarcinoma Using a Bioinformatics Strategy: A Study Based on Datasets from The Cancer Genome Atlas 